? What Is The Oncomine Myeloid DNA Panel Test?
The Oncomine Myeloid DNA Panel is a specialized next-generation sequencing (NGS) test designed to detect critical somatic mutations in genes associated with myeloid malignancies. It plays a key role in the diagnosis, classification, prognosis, and treatment planning of diseases such as Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS), and Myeloproliferative Neoplasms (MPNs).

? Why Do People In Dubai Choose This Test?

✔️ Targets over 40 clinically relevant genes (e.g., TP53, FLT3, DNMT3A, IDH1/2, ASXL1, NPM1)
✔️ Helps in confirming diagnosis and risk stratification
✔️ Supports selection of targeted therapies and clinical trial eligibility
✔️ Enables early detection of clonal hematopoiesis
✔️ Trusted by leading hematologists and oncologists across Dubai

? Methodology Of The Test

1. Sample Collection:
   A peripheral blood sample or bone marrow aspirate is collected by a certified healthcare professional.

2. DNA Extraction:
   Genomic DNA is extracted from the sample for analysis.

3. NGS Sequencing:
   The sample undergoes high-depth sequencing using NGS technology, identifying single nucleotide variants (SNVs), insertions, deletions, and copy number alterations.

4. Bioinformatics Analysis:
   Results are interpreted using advanced tools to determine clinical significance of the detected mutations.

5. Clinical Report:
   A clear, actionable report is generated within 10–14 business days, guiding physicians in diagnosis and treatment.

? When Should You Take This Test?

• If diagnosed with AML, MDS, MPN, or other myeloid neoplasms
• When abnormal blood counts or bone marrow results are present
• To identify targetable mutations before treatment
• Prior to considering stem cell transplant or targeted therapies
• As part of a comprehensive leukemia workup

? Cost Of Oncomine Myeloid DNA Panel In Dubai

The price generally ranges from AED 3,500 – AED 7,500, based on the lab, number of genes tested, and additional medical consultations provided.

?‍♀️ Frequently Asked Questions (FAQ)

Q1: What does the Oncomine Myeloid DNA Panel detect?
It detects somatic mutations associated with various myeloid blood cancers, helping guide personalized treatment.

Q2: Is this test used only for confirmed leukemia patients?
No. It can also be used for suspected cases, monitoring relapse, or when standard tests are inconclusive.

Q3: Can I do this test with just a blood sample?
Yes, in many cases a blood sample is enough. A bone marrow sample may be required in certain scenarios.

Q4: Does the test help determine treatment?
Absolutely. It helps in choosing targeted therapies and evaluating clinical trial options based on genetic profile.

Q5: How soon can I get the results?
Results are typically delivered in 10 to 14 working days, along with a detailed clinical interpretation.

✅ Conclusion
The Oncomine Myeloid DNA Panel is a vital diagnostic tool for anyone affected by or suspected of having myeloid malignancies. With its ability to detect a wide range of critical mutations, it empowers doctors in Dubai to provide precise, personalized treatment plans. Whether for initial diagnosis, treatment planning, or relapse monitoring, this test brings clarity and confidence. If you or your loved one is being evaluated for blood disorders, ask your physician about the Oncomine Myeloid DNA Panel today.